Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed
DSpace/Manakin Repository
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed
International BFM Study Group (I-BFM), Innovative Therapies for Children with Cancer (ITCC), and the European Society for Paediatric Oncology (SIOPE)
(2024) Journal of clinical oncology : official journal of the American Society of Clinical Oncology, volume 42, issue 3, pp. 253 - 257
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: Journal Article
DOI:
https://doi.org/10.1200/JCO.23.01314
ISSN: 0732-183X
Publisher: Lippincott Williams & Wilkins
(Peer reviewed)